Cg Oncology Inc. Earnings

Cg Oncology Inc.’s revenue fell -90.17% since last year same period to $0.05Mn in the Q1 2025. On a quarterly growth basis, Cg Oncology Inc. has generated -88.6% fall in its revenue since last 3-months.

Cg Oncology Inc.’s net profit fell -103.47% since last year same period to $-34.45Mn in the Q1 2025. On a quarterly growth basis, Cg Oncology Inc. has generated -8.35% fall in its net profits since last 3-months.

Cg Oncology Inc.’s net profit margin fell -1969.94% since last year same period to -66253.85% in the Q1 2025. On a quarterly growth basis, Cg Oncology Inc. has generated -850.11% fall in its net profit margins since last 3-months.

Cg Oncology Inc.’s earning per share (EPS) estimates for the current quarter stand at 0 - a 100% jump from last quarter’s estimates.

Cg Oncology Inc.’s earning per share (EPS) estimates for the current year stand at 0.

Cg Oncology Inc.’s earning per share (EPS) jumped 100% since last year same period to 0 in the Q2 2025. This indicates that the Cg Oncology Inc. has generated 100% annual rate of jump in its earning per share (EPS) in the last 4 quarters.